Norris Medicines Limited (NORRIS.BO)
INR 19.21
(-1.99%)
INR 19.21
(-1.99%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 11.15 Million INR | 274.67% |
| 2022 | 2.97 Million INR | 141.37% |
| 2021 | -7.19 Million INR | 70.12% |
| 2020 | -24.08 Million INR | 15.34% |
| 2019 | -28.45 Million INR | -117.15% |
| 2018 | -13.1 Million INR | 49.55% |
| 2017 | -25.97 Million INR | -353.98% |
| 2016 | -5.72 Million INR | -240.61% |
| 2015 | 4.06 Million INR | -21.93% |
| 2014 | 5.21 Million INR | 123.59% |
| 2013 | -22.09 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2.93 Million INR | -184.6% |
| 2023 Q1 | -5.28 Million INR | -240.9% |
| 2023 FY | -7.56 Million INR | -354.0% |
| 2023 Q4 | 3.46 Million INR | 288.02% |
| 2023 Q3 | -1.84 Million INR | 52.72% |
| 2023 Q2 | -3.9 Million INR | 26.25% |
| 2022 Q3 | 1.84 Million INR | 116.84% |
| 2022 FY | 2.97 Million INR | 141.37% |
| 2022 Q1 | -3.46 Million INR | 67.27% |
| 2022 Q2 | 849 Thousand INR | 124.51% |
| 2022 Q4 | 3.75 Million INR | 103.85% |
| 2021 FY | -7.19 Million INR | 70.12% |
| 2021 Q4 | -10.58 Million INR | -484.63% |
| 2021 Q3 | 2.75 Million INR | 194.9% |
| 2021 Q2 | -2.9 Million INR | -182.06% |
| 2021 Q1 | 3.53 Million INR | 129.86% |
| 2020 Q4 | -11.83 Million INR | -2620.9% |
| 2020 FY | -24.08 Million INR | 15.34% |
| 2020 Q3 | -435 Thousand INR | 95.72% |
| 2020 Q2 | -10.15 Million INR | -511.56% |
| 2020 Q1 | -1.66 Million INR | 84.48% |
| 2019 Q4 | -10.7 Million INR | -89.49% |
| 2019 FY | -28.45 Million INR | -117.15% |
| 2019 Q1 | -3.13 Million INR | -144.07% |
| 2019 Q2 | -8.98 Million INR | -187.03% |
| 2019 Q3 | -5.64 Million INR | 37.14% |
| 2018 Q1 | -8 Million INR | -59.45% |
| 2018 FY | -13.1 Million INR | 49.55% |
| 2018 Q4 | 7.1 Million INR | 190.38% |
| 2018 Q3 | -7.85 Million INR | -28.33% |
| 2018 Q2 | -6.12 Million INR | 23.45% |
| 2017 Q2 | -9.9 Million INR | -33.87% |
| 2017 FY | -25.97 Million INR | -353.98% |
| 2017 Q1 | -7.39 Million INR | -2.55% |
| 2017 Q4 | -5.01 Million INR | -45.6% |
| 2017 Q3 | -3.44 Million INR | 65.21% |
| 2016 Q3 | 1.68 Million INR | 111.67% |
| 2016 Q2 | 797 Thousand INR | 175.62% |
| 2016 Q1 | -1.05 Million INR | -171.43% |
| 2016 FY | -5.72 Million INR | -240.61% |
| 2016 Q4 | -7.21 Million INR | -527.62% |
| 2015 FY | 4.06 Million INR | -21.93% |
| 2015 Q3 | -168 Thousand INR | -105.99% |
| 2015 Q2 | 2.8 Million INR | 382.95% |
| 2015 Q1 | -991 Thousand INR | -115.93% |
| 2015 Q4 | 1.47 Million INR | 978.33% |
| 2014 Q1 | 1.59 Million INR | 0.0% |
| 2014 FY | 5.21 Million INR | 123.59% |
| 2014 Q2 | 289 Thousand INR | -81.82% |
| 2014 Q3 | 949 Thousand INR | 228.37% |
| 2014 Q4 | 6.21 Million INR | 555.38% |
| 2013 FY | -22.09 Million INR | 0.0% |
| 2013 Q3 | 1.83 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -1998.001% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 129.55% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 88.692% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 81.792% |
| Sunil Healthcare Limited | -19.98 Million INR | 155.839% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | 32.113% |
| MedPlus Health Services Limited | 1.31 Billion INR | 99.155% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 106.97% |
| Patidar Buildcon Limited | -1.83 Million INR | 707.689% |
| Roopa Industries Limited | 48.05 Million INR | 76.783% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Trident Lifeline Limited | 72.21 Million INR | 84.549% |
| PANJON LTD. | - INR | -Infinity% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 107.472% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | -24.106% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 162.271% |
| Anuh Pharma Limited | 682.19 Million INR | 98.365% |
| Crestchem Limited | 27.25 Million INR | 59.065% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 194.914% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | 34.849% |
| Tyche Industries Limited | 111.22 Million INR | 89.969% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 96.937% |
| Trimurthi Limited | -6.14 Million INR | 281.623% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 95.278% |
| Zenlabs Ethica Limited | 89.27 Million INR | 87.503% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 96.713% |
| ANG Lifesciences India Limited | 12.8 Million INR | 12.869% |
| Parmax Pharma Limited | 3.75 Million INR | -197.164% |
| Veerhealth Care Limited | 34.19 Million INR | 67.369% |
| Deccan Health Care Limited | 185.32 Million INR | 93.98% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 94.827% |
| Makers Laboratories Limited | -34.91 Million INR | 131.96% |
| Lactose (India) Limited | 137.78 Million INR | 91.903% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 109.029% |
| Zenith Healthcare Limited | 196 Thousand INR | -5592.433% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 82.694% |
| Bacil Pharma Limited | -1.89 Million INR | 688.974% |
| PRAVEG LIMITED | 185.06 Million INR | 93.971% |
| Denis Chem Lab Limited | 142.87 Million INR | 92.191% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 97.772% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 98.332% |
| Colinz Laboratories Limited | 14.64 Million INR | 23.805% |
| Godavari Drugs Limited | -67.67 Million INR | 116.487% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 2848.071% |
| Zenotech Laboratories Limited | 242.37 Million INR | 95.397% |
| Panchsheel Organics Limited | 288.28 Million INR | 96.13% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 98.051% |
| Vivanza Biosciences Limited | 14.83 Million INR | 24.776% |
| Phaarmasia Limited | - INR | -Infinity% |
| Sastasundar Ventures Limited | -229.64 Million INR | 104.858% |
| Medi-Caps Limited | -17.21 Million INR | 164.83% |
| DECIPHER LABS LIMITED | 53.74 Million INR | 79.239% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 98.694% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 97.446% |
| Mercury Laboratories Limited | 62.14 Million INR | 82.047% |
| Gennex Laboratories Limited | 146.61 Million INR | 92.39% |
| BDH Industries Limited | 169.01 Million INR | 93.399% |
| Coral Laboratories Limited | 142.63 Million INR | 92.178% |
| Concord Drugs Limited | 24.87 Million INR | 55.142% |
| Bharat Parenterals Limited | 733.49 Million INR | 98.479% |
| Beryl Drugs Limited | 14.73 Million INR | 24.266% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 209.955% |
| Evoq Remedies Limited | 42.91 Million INR | 74.003% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 85.617% |
| Transchem Limited | -17.43 Million INR | 163.978% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -40.025% |
| Parnax Lab Limited | 166.84 Million INR | 93.313% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 67.334% |
| Kerala Ayurveda Limited | 48.04 Million INR | 76.778% |
| Cian Healthcare Limited | 53.96 Million INR | 79.327% |
| Trinity League India Limited | 1.17 Million INR | -851.165% |
| Syschem (India) Limited | 504.91 Million INR | 97.79% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 549.886% |
| Natural Capsules Limited | 112.4 Million INR | 90.074% |
| Auro Laboratories Limited | 95.77 Million INR | 88.351% |